Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
CardiovascularVAGINALGeneric

NYSTATIN

NYSTATIN

Standard Dose
100,000 UNITS
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NYSTATIN is listed in Drugs@FDA under application 062615 (ANDA).

Marketing status: Discontinued Active ingredient NYSTATIN Form and strength TABLET;VAGINAL - 100,000 UNITS Sponsor ODYSSEY PHARMS Submission history Latest submission status date: 2001-05-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview NYSTATIN is listed in Drugs@FDA under application 062615 (ANDA). Marketing status: Discontinued Active ingredient NYSTATIN Form and strength TABLET;VAGINAL - 100,000 UNITS Sponsor ODYSSEY PHARMS Submission history Latest submission status date: 2001-05-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.